Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 317

1.

New video fluoroscopic chewing examination for patients who use dentures after mandibular reconstruction.

Hayashi T, Kuribayashi K, Maeda T, Yamamoto Y.

Br J Oral Maxillofac Surg. 2019 Jun 14. pii: S0266-4356(19)30209-8. doi: 10.1016/j.bjoms.2019.05.014. [Epub ahead of print] No abstract available.

PMID:
31208788
2.

Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial.

Scagliotti GV, Gaafar R, Nowak AK, Nakano T, van Meerbeeck J, Popat S, Vogelzang NJ, Grosso F, Aboelhassan R, Jakopovic M, Ceresoli GL, Taylor P, Orlandi F, Fennell DA, Novello S, Scherpereel A, Kuribayashi K, Cedres S, Sørensen JB, Pavlakis N, Reck M, Velema D, von Wangenheim U, Kim M, Barrueco J, Tsao AS.

Lancet Respir Med. 2019 Jul;7(7):569-580. doi: 10.1016/S2213-2600(19)30139-0. Epub 2019 May 15.

PMID:
31103412
3.

Effects of two types of smartphone-based stress management programmes on depressive and anxiety symptoms among hospital nurses in Vietnam: a protocol for three-arm randomised controlled trial.

Imamura K, Tran TTT, Nguyen HT, Kuribayashi K, Sakuraya A, Nguyen AQ, Bui TM, Nguyen QT, Nguyen KT, Nguyen GTH, Tran XTN, Truong TQ, Zhang MWB, Minas H, Sekiya Y, Sasaki N, Tsutsumi A, Kawakami N.

BMJ Open. 2019 Apr 8;9(4):e025138. doi: 10.1136/bmjopen-2018-025138.

4.

Air pollution in the Asia-Pacific Region: A Joint Asian Pacific Society of Respirology/American Thoracic Society perspective (Republication).

North CM, Rice MB, Ferkol T, Gozal D, Hui C, Jung SH, Kuribayashi K, McCormack MC, Mishima M, Morimoto Y, Song Y, Wilson KC, Kim WJ, Fong KM.

Respirology. 2019 May;24(5):484-491. doi: 10.1111/resp.13531. Epub 2019 Mar 28. Review. No abstract available.

5.

Analysis of Pleiotropic Effects of Nivolumab in Pretreated Advanced or Recurrent Non-small Cell Lung Cancer Cases.

Akano Y, Kuribayashi K, Funaguchi N, Koda Y, Fujimoto E, Mikami K, Minami T, Takahashi R, Yokoi T, Kijima T.

In Vivo. 2019 Mar-Apr;33(2):507-514. doi: 10.21873/invivo.11503.

7.

Air Pollution in the Asia-Pacific Region. A Joint Asian Pacific Society of Respirology/American Thoracic Society Perspective.

North CM, Rice MB, Ferkol T, Gozal D, Hui C, Jung SH, Kuribayashi K, McCormack MC, Mishima M, Morimoto Y, Song Y, Wilson KC, Kim WJ, Fong KM.

Am J Respir Crit Care Med. 2019 Mar 15;199(6):693-700. doi: 10.1164/rccm.201804-0673PP. No abstract available.

PMID:
30508489
8.

Early-stage Clinical Characterization of Malignant Pleural Mesothelioma.

Negi Y, Kuribayashi K, Funaguchi N, Doi H, Mikami K, Minami T, Takuwa T, Yokoi T, Hasegawa S, Kijima T.

In Vivo. 2018 Sep-Oct;32(5):1169-1174. doi: 10.21873/invivo.11360.

9.

Double cancer comprising malignant pleural mesothelioma and squamous cell carcinoma of the lung treated with radiotherapy: A case report.

Negi Y, Kuribayashi K, Doi H, Funaguchi N, Koda Y, Fujimoto E, Mikami K, Minami T, Yokoi T, Kijima T.

Mol Clin Oncol. 2018 Aug;9(2):181-186. doi: 10.3892/mco.2018.1650. Epub 2018 Jun 11.

10.

Differences in the Effect of Internet-Based Cognitive Behavioral Therapy for Improving Nonclinical Depressive Symptoms Among Workers by Time Preference: Randomized Controlled Trial.

Imamura K, Furukawa TA, Matsuyama Y, Shimazu A, Kuribayashi K, Kasai K, Kawakami N.

J Med Internet Res. 2018 Aug 10;20(8):e10231. doi: 10.2196/10231.

11.

Utility of polaprezinc in reducing toxicities during radiotherapy: a literature review.

Doi H, Kuribayashi K, Kijima T.

Future Oncol. 2018 Aug;14(19):1977-1988. doi: 10.2217/fon-2018-0021. Epub 2018 Aug 3. Review.

PMID:
30074413
12.

Effects of Storage Conditions on Dissolution Rates of Indomethacin Capsules.

Kuribayashi K, Takabatake T, Mizuno K.

Chem Pharm Bull (Tokyo). 2018;66(8):779-784. doi: 10.1248/cpb.c17-00971.

13.

Successful Treatment of Pulmonary Pleomorphic Carcinoma with Nivolumab: A Case Report.

Fujimoto E, Yokoi T, Mikami K, Kanemura S, Shibata E, Horio D, Koda Y, Negi Y, Akano Y, Tada A, Minami T, Kuribayashi K, Kijima T.

Case Rep Oncol. 2018 May 31;11(2):336-340. doi: 10.1159/000489392. eCollection 2018 May-Aug.

14.

Factors impacting the efficacy of venlafaxine extended release 75-225 mg/day in patients with major depressive disorder: exploratory post hoc subgroup analyses of a randomized, double-blind, placebo-controlled study in Japan.

Watanabe Y, Asami Y, Hirano Y, Kuribayashi K, Itamura R, Imaeda T.

Neuropsychiatr Dis Treat. 2018 May 16;14:1261-1272. doi: 10.2147/NDT.S146428. eCollection 2018.

15.

Possibility of Database Research as a Means of Pharmacovigilance in Japan Based on a Comparison with Sertraline Postmarketing Surveillance.

Hirano Y, Asami Y, Kuribayashi K, Kitazaki S, Yamamoto Y, Fujimoto Y.

Value Health Reg Issues. 2018 May;15:1-5. doi: 10.1016/j.vhri.2017.05.002. Epub 2017 Jun 20.

PMID:
29474173
16.

Stereotactic Body Radiation Therapy for Liver Tumors: Current Status and Perspectives.

Doi H, Beppu N, Kitajima K, Kuribayashi K.

Anticancer Res. 2018 Feb;38(2):591-599. Review.

PMID:
29374681
17.

Contact Dermatitis after Prescription of an Ophthalmic Ointment Containing Fradiomycin Sulfate: A Retrospective Database Study Using Japanese Health Insurance Claims Data.

Sugimoto N, Kuribayashi K, Yamamoto Y, Nagayasu S, Suga O, Fujimoto Y.

Drugs Real World Outcomes. 2018 Mar;5(1):45-54. doi: 10.1007/s40801-017-0127-4.

18.

Regioregular Phthalocyanines Substituted with Bulky Donors at Non-Peripheral Positions.

Yamamoto S, Kuribayashi K, Murakami TN, Kwon E, Stillman MJ, Kobayashi N, Segawa H, Kimura M.

Chemistry. 2017 Nov 2;23(61):15446-15454. doi: 10.1002/chem.201703105. Epub 2017 Oct 13.

PMID:
28884850
19.

First-line chemotherapy with pemetrexed plus cisplatin for malignant peritoneal mesothelioma.

Fujimoto E, Kijima T, Kuribayashi K, Negi Y, Kanemura S, Mikami K, Doi H, Kitajima K, Nakano T.

Expert Rev Anticancer Ther. 2017 Sep;17(9):865-872. doi: 10.1080/14737140.2017.1340157. Epub 2017 Jun 15.

PMID:
28594258
20.

The AMPK/mTOR pathway is involved in D-dopachrome tautomerase gene transcription in adipocytes differentiated from SGBS cells, a human preadipocyte cell line.

Iwata T, Kuribayashi K, Nakasono M, Saito-Tarashima N, Minakawa N, Mizusawa N, Kido R, Yoshimoto K.

Cytokine. 2017 Aug;96:195-202. doi: 10.1016/j.cyto.2017.04.017. Epub 2017 Apr 25.

PMID:
28445821
21.

Pemetrexed for epithelioid haemangioendothelioma of the pleura.

Kanemura S, Kuribayashi K, Moriya Y, Shimizu S, Tsujimura T, Nakano T.

Respirol Case Rep. 2016 Sep 25;4(6):e00191. doi: 10.1002/rcr2.191. eCollection 2016 Nov.

22.

Metabolic response assessment with 18F-FDG-PET/CT is superior to modified RECIST for the evaluation of response to platinum-based doublet chemotherapy in malignant pleural mesothelioma.

Kanemura S, Kuribayashi K, Funaguchi N, Shibata E, Mikami K, Doi H, Kitajima K, Hasegawa S, Nakano T.

Eur J Radiol. 2017 Jan;86:92-98. doi: 10.1016/j.ejrad.2016.11.009. Epub 2016 Nov 5.

PMID:
28027772
23.

Prognostic value of pretreatment volume-based quantitative 18F-FDG PET/CT parameters in patients with malignant pleural mesothelioma.

Kitajima K, Doi H, Kuribayashi K, Hashimoto M, Tsuchitani T, Tanooka M, Fukushima K, Nakano T, Hasegawa S, Hirota S.

Eur J Radiol. 2017 Jan;86:176-183. doi: 10.1016/j.ejrad.2016.11.019. Epub 2016 Nov 15.

PMID:
28027744
24.

Challenge of ex vivo-stimulated CD4+CD25+ regulatory T cell-mediated alloantigen-specific immunosuppression by murine cardiac transplantation.

Hori T, Uemoto S, Saito K, Kuribayashi K, Hori Y, Kato T.

Transpl Immunol. 2017 Feb;40:72-73. doi: 10.1016/j.trim.2016.12.005. Epub 2016 Dec 23. No abstract available.

PMID:
28017878
25.

Dosage, effectiveness, and safety of sertraline treatment for posttraumatic stress disorder in a Japanese clinical setting: a retrospective study.

Kamo T, Maeda M, Oe M, Kato H, Shigemura J, Kuribayashi K, Hoshino Y.

BMC Psychiatry. 2016 Dec 7;16(1):434.

26.

Possible new therapeutic agents for malignant pleural mesothelioma: anti-CD26 monoclonal antibody and naftopidil.

Nakano T, Kuribayashi K, Mikami K.

Expert Rev Anticancer Ther. 2016 Nov;16(11):1097-1099. doi: 10.1080/14737140.2016.1241150. Epub 2016 Oct 8. No abstract available.

PMID:
27718761
27.

Chemotherapy for advanced non-small cell lung cancer with a focus on squamous cell carcinoma.

Kuribayashi K, Funaguchi N, Nakano T.

J Cancer Res Ther. 2016 Apr-Jun;12(2):528-34. doi: 10.4103/0973-1482.174185. Review.

28.

Present and future roles of FDG-PET/CT imaging in the management of malignant pleural mesothelioma.

Kitajima K, Doi H, Kuribayashi K.

Jpn J Radiol. 2016 Aug;34(8):537-47. doi: 10.1007/s11604-016-0555-1. Epub 2016 May 24. Review.

PMID:
27222020
29.

Present and future roles of FDG-PET/CT imaging in the management of lung cancer.

Kitajima K, Doi H, Kanda T, Yamane T, Tsujikawa T, Kaida H, Tamaki Y, Kuribayashi K.

Jpn J Radiol. 2016 Jun;34(6):387-99. doi: 10.1007/s11604-016-0546-2. Epub 2016 Apr 27. Review.

PMID:
27121156
30.

A randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of venlafaxine extended release and a long-term extension study for patients with major depressive disorder in Japan.

Higuchi T, Kamijima K, Nakagome K, Itamura R, Asami Y, Kuribayashi K, Imaeda T.

Int Clin Psychopharmacol. 2016 Jan;31(1):8-19. doi: 10.1097/YIC.0000000000000105.

31.

Epithelioid pleural mesothelioma concurrently associated with miliary pulmonary metastases and minimal change nephrotic syndrome - A hitherto undescribed case.

Tsukamoto Y, Otsuki T, Hao H, Kuribayashi K, Nakano T, Kida A, Nakanishi T, Funatsu E, Noguchi C, Yoshihara S, Kaku K, Hirota S.

Pathol Res Pract. 2015 Dec;211(12):1014-9. doi: 10.1016/j.prp.2015.07.013. Epub 2015 Sep 5.

PMID:
26376466
32.

Possible practical utility of an enzyme cocktail produced by sludge-degrading microbes for methane and hydrogen production from digested sludge.

Sato H, Kuribayashi K, Fujii K.

N Biotechnol. 2016 Jan 25;33(1):1-6. doi: 10.1016/j.nbt.2015.07.003. Epub 2015 Aug 3.

PMID:
26248274
33.

Diagnostic relevance of autoantibody detection against inhibitors of apoptosis proteins in colon cancer and colon adenoma.

Hosono Y, Goto M, Kobayashi D, Kuribayashi K, Tanaka M, Watanabe N.

Mol Clin Oncol. 2015 May;3(3):595-600. Epub 2015 Feb 6.

34.

Suppression of heme oxygenase-1 activity reduces airway hyperresponsiveness and inflammation in a mouse model of asthma.

Kuribayashi K, Iida S, Nakajima Y, Funaguchi N, Tabata C, Fukuoka K, Fujimori Y, Ihaku D, Nakano T.

J Asthma. 2015 Sep;52(7):662-8. doi: 10.3109/02770903.2015.1008138. Epub 2015 Jul 2.

PMID:
26133060
35.
36.

Ultraviolet-induced alloantigen-specific immunosuppression in transplant immunity.

Hori T, Kuribayashi K, Saito K, Wang L, Torii M, Uemoto S, Iida T, Yagi S, Kato T.

World J Transplant. 2015 Mar 24;5(1):11-8. doi: 10.5500/wjt.v5.i1.11. Review.

37.

Significance of SALL4 as a drug‑resistant factor in lung cancer.

Yanagihara N, Kobayashi D, Kuribayashi K, Tanaka M, Hasegawa T, Watanabe N.

Int J Oncol. 2015 Apr;46(4):1527-34. doi: 10.3892/ijo.2015.2866. Epub 2015 Feb 3.

PMID:
25646965
38.

Adenosine deaminase inhibitor EHNA exhibits a potent anticancer effect against malignant pleural mesothelioma.

Nakajima Y, Kanno T, Nagaya T, Kuribayashi K, Nakano T, Gotoh A, Nishizaki T.

Cell Physiol Biochem. 2015;35(1):51-60. doi: 10.1159/000369674. Epub 2015 Jan 2.

39.
40.

Significance of serine threonine tyrosine kinase 1 as a drug resistance factor and therapeutic predictor in acute leukemia.

Nirasawa S, Kobayashi D, Kondoh T, Kuribayashi K, Tanaka M, Yanagihara N, Watanabe N.

Int J Oncol. 2014 Nov;45(5):1867-74. doi: 10.3892/ijo.2014.2633. Epub 2014 Sep 3.

PMID:
25190507
41.

Identification of a bacteriolysis-associated virulence factor against lung epithelial cells in Pseudomonas aeruginosa PAO-1 cell lysate.

Shinagawa M, Kobayashi D, Goto M, Tanaka M, Kuribayashi K, Yanagihara N, Watanabe N.

Microb Pathog. 2014 Oct;75:35-40. doi: 10.1016/j.micpath.2014.08.002. Epub 2014 Aug 23.

PMID:
25152458
42.

C-reactive protein reduces the relative number of tumor-associated M2 macrophages and intratumoral angiogenesis in mice.

Kuribayashi K, Motoyama S, Sasaki T, Sato Y, Yoshino K, Wakita A, Imai K, Saito H, Minamiya Y.

Tohoku J Exp Med. 2014 Aug;233(4):249-55.

43.

Stanniocalcin-1 promotes metastasis in a human breast cancer cell line through activation of PI3K.

Murai R, Tanaka M, Takahashi Y, Kuribayashi K, Kobayashi D, Watanabe N.

Clin Exp Metastasis. 2014 Oct;31(7):787-94. doi: 10.1007/s10585-014-9668-z. Epub 2014 Jul 24.

PMID:
25056605
44.

Cell-adhesion molecule expression and the proliferation of malignant mesothelioma: a post-mortem examination.

Kuribayashi K, Hirano H, Nakasho K, Ohyama H, Yamanegi K, Tabata C, Fukuoka K, Fujimori Y, Nakano T.

Anticancer Res. 2014 Jun;34(6):3061-5.

PMID:
24922673
45.

CD7 promotes extramedullary involvement of the B-cell acute lymphoblastic leukemia line Tanoue by enhancing integrin β2-dependent cell adhesiveness.

Kondoh T, Kuribayashi K, Tanaka M, Kobayashi D, Yanagihara N, Watanabe N.

Int J Oncol. 2014 Sep;45(3):1073-81. doi: 10.3892/ijo.2014.2492. Epub 2014 Jun 11.

PMID:
24920488
46.

Protein kinase C ζ regulates survivin expression and inhibits apoptosis in colon cancer.

Umemori Y, Kuribayashi K, Nirasawa S, Kondoh T, Tanaka M, Kobayashi D, Watanabe N.

Int J Oncol. 2014 Sep;45(3):1043-50. doi: 10.3892/ijo.2014.2489. Epub 2014 Jun 10.

PMID:
24920238
47.

Prophylactic and therapeutic effects of Acanthopanax senticosus Harms extract on murine collagen-induced arthritis.

Takahashi Y, Tanaka M, Murai R, Kuribayashi K, Kobayashi D, Yanagihara N, Watanabe N.

Phytother Res. 2014 Oct;28(10):1513-9. doi: 10.1002/ptr.5157. Epub 2014 May 2.

48.

Structure-activity relationship study, target identification, and pharmacological characterization of a small molecular IL-12/23 inhibitor, APY0201.

Hayakawa N, Noguchi M, Takeshita S, Eviryanti A, Seki Y, Nishio H, Yokoyama R, Noguchi M, Shuto M, Shima Y, Kuribayashi K, Kageyama S, Eda H, Suzuki M, Hatta T, Iemura S, Natsume T, Tanabe I, Nakagawa R, Shiozaki M, Sakurai K, Shoji M, Andou A, Yamamoto T.

Bioorg Med Chem. 2014 Jun 1;22(11):3021-9. doi: 10.1016/j.bmc.2014.03.036. Epub 2014 Apr 13.

PMID:
24767819
49.

Combined serum mesothelin and carcinoembryonic antigen measurement in the diagnosis of malignant mesothelioma.

Fukuoka K, Kuribayashi K, Yamada S, Tamura K, Tabata C, Nakano T.

Mol Clin Oncol. 2013 Nov;1(6):942-948. Epub 2013 Sep 2.

50.

Methotrexate and gemcitabine combination chemotherapy for the treatment of malignant pleural mesothelioma.

Kuribayashi K, Miyata S, Fukuoka K, Murakami A, Yamada S, Tamura K, Hirayama N, Terada T, Tabata C, Fujimori Y, Nakano T.

Mol Clin Oncol. 2013 Jul;1(4):639-642. Epub 2013 May 10.

Supplemental Content

Loading ...
Support Center